Original ResearchPublished 24 September 2026Integrative multi-omics characterization of KLRB1/CD161 in diffuse large B-cell lymphoma: associations with immune context, subtype biology, and therapeutic responseErwei Li · Yingying Tang · Yuanyuan Wanyan · Yu LiangFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1903725
ReviewPublished 18 May 2026Pathogenesis of diabetic cardiomyopathy and emerging therapeutic strategies: a network-based perspectiveHaoqing Ren · Hengli LaiFrontiers in Clinical Diabetes and Healthcaredoi 10.3389/fcdhc.2026.1823872
Original ResearchPublished 21 January 2026Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemiaMuluken Megiso · Chidiebube Ugwu · Elvis Obomanu · Alankrita TanejaFrontiers in Hematologydoi 10.3389/frhem.2025.1730554
